According to Novo Nordisk latest financial reports the total liabilities of NVO is $28.96B, an increase of 31.79% to 2022. At the end of 2022 company had $21.98B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Novo Nordisk is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $28.96B | 31.79% |
2022 | $21.98B | 27.48% |
2021 | $17.24B | 51.67% |
2020 | $11.37B | 19.96% |
2019 | $9.47B | 631.78% |
2018 | $1.29B | - |